Lexeo Therapeutics, Inc.盘中异动早盘股价大跌5.19%报3.20美元

市场透视2025-02-26

北京时间2025年02月26日23时17分，Lexeo Therapeutics, Inc.（LXEO.us）股票出现异动，股价快速跳水5.19%。截至发稿，该股报3.20美元/股，成交量12.7855万股，换手率0.39%，振幅6.52%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-29.49百万美元，每股收益-0.89美元，毛利-509000.00美元，市盈率-0.26倍。机构...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2514085472?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-02-26 23:17","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2514085472","market":"us","top_or_hot":-1,"title":"Lexeo Therapeutics, Inc.盘中异动 早盘股价大跌5.19%报3.20美元","media":"市场透视","content":"<div>\n<p>北京时间2025年02月26日23时17分，Lexeo Therapeutics, Inc.（LXEO.us）股票出现异动，股价快速跳水5.19%。截至发稿，该股报3.20美元/股，成交量12.7855万股，换手率0.39%，振幅6.52%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-29.49百万美元，每股收益-0.89美元，毛利-509000.00美元，市盈率-0.26倍。机构...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502262317219893b3ba&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Lexeo Therapeutics, Inc.盘中异动 早盘股价大跌5.19%报3.20美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLexeo Therapeutics, Inc.盘中异动 早盘股价大跌5.19%报3.20美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-02-26 23:17 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502262317219893b3ba&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2025年02月26日23时17分，Lexeo Therapeutics, Inc.（LXEO.us）股票出现异动，股价快速跳水5.19%。截至发稿，该股报3.20美元/股，成交量12.7855万股，换手率0.39%，振幅6.52%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-29.49百万美元，每股收益-0.89美元，毛利-509000.00美元，市盈率-0.26倍。机构...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502262317219893b3ba&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LXEO","symbol_name":"Lexeo Therapeutics","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502262317219893b3ba&s=b","article_id":"2514085472","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502262317219893b3ba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2514085472","pubTimestamp":1740583041,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2025年02月26日23时17分，Lexeo Therapeutics, Inc.股票出现异动，股价快速跳水5.19%。Lexeo Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.07%。其相关个股中，Enveric Biosciences, Inc.、Renovaro Inc.、Athira Pharma, Inc.涨幅较大，Enveric Biosciences, Inc.、Organovo Holdings, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为5009.26%、179.49%、158.89%，振幅较大的相关个股有Enveric Biosciences, Inc.、Humacyte Inc C/Wts 27/08/2026 、Organovo Holdings, Inc.，振幅分别为161.02%、39.47%、33.94%。Lexeo Therapeutics, Inc.公司简介：Lexeo Therapeutics Inc 是一家临床阶段的基因药物公司，致力于通过应用前沿科学从根本上改变疾病的治疗方式来改变医疗保健。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LXEO":"Lexeo Therapeutics","LENZ":"Therapeutics","BK4139":"生物科技"},"translate_title":"Lexeo Therapeutics, Inc. shares fell 5.19% to $3.20 in early trading","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LENZ":1,"LXEO":1},"content_text":"北京时间2025年02月26日23时17分，Lexeo Therapeutics, Inc.（LXEO.us）股票出现异动，股价快速跳水5.19%。截至发稿，该股报3.20美元/股，成交量12.7855万股，换手率0.39%，振幅6.52%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-29.49百万美元，每股收益-0.89美元，毛利-509000.00美元，市盈率-0.26倍。机构评级方面，在所有7家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Lexeo Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.07%。其相关个股中，Enveric Biosciences, Inc.、Renovaro Inc.、Athira Pharma, Inc.涨幅较大，Enveric Biosciences, Inc.、Organovo Holdings, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为5009.26%、179.49%、158.89%，振幅较大的相关个股有Enveric Biosciences, Inc.、Humacyte Inc C/Wts 27/08/2026 (To Pur Com)、Organovo Holdings, Inc.，振幅分别为161.02%、39.47%、33.94%。Lexeo Therapeutics, Inc.公司简介：Lexeo Therapeutics Inc 是一家临床阶段的基因药物公司，致力于通过应用前沿科学从根本上改变疾病的治疗方式来改变医疗保健。其产品线包括针对给社会带来重大负担且最适合其基因医学方法的患者群体的候选药物。该公司专注于临床前和临床阶段的基因治疗，特别是高未满足需求的遗传性和后天性疾病，这是他们唯一的业务分部。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2514085472","isCrawlerRequest":true}

Lexeo Therapeutics, Inc.盘中异动 早盘股价大跌5.19%报3.20美元

精彩评论

Lexeo Therapeutics, Inc.盘中异动早盘股价大跌5.19%报3.20美元